New FDA Safety Alert

Share this story on:

Share on facebook
Share on twitter
Share on linkedin

“According to a July 26 released FDA advisory these medications have been associated with disabling and potentially permanent side effects involving tendons, muscles and/or joints, as well as peripheral nerves and the central nervous system. Some patients may even experience more than one such adverse effect.

“Therefore, said FDA officials, fluoroquinolones should be used in patients with acute bacterial sinusitis (ABS), acute bacterial exacerbation of chronic bronchitis (ABECB) or uncomplicated urinary tract infections (UTIs) only when no other treatment options are available, “because the risk of these serious side effects generally outweighs the benefits in these patients.”

“Fluoroquinolones have risks and benefits that should be considered very carefully,” said Edward Cox, M.D., director of the Office of Antimicrobial Products in the agency’s Center for Drug Evaluation and Research…”  Source:  American Academy of Family Physicians.  For details click here.

Teresa
Teresa

Recent Posts

Teresa

Indiana Update

Over 954,000 people in the state of Indiana have been fully vaccinated against COVID-19. There are 548 people in Indiana hospitals because of COVID-19; and

Read More »
Teresa

Unprecedented Collaboration

“… COVID 19 has led to unprecedented worldwide collaboration among scientists, medical doctors, health and government officials, and manufacturers…The arrival of this vaccine in Michigan

Read More »
Teresa

Questions about Vaccines?

“People with questions about vaccines – including the COVID 19 vaccination should consult a creditable source with answers based on medical science.  Sources for vaccination

Read More »

copyright 2020 Evansville Insurance Center